Various biomarkers like estrogen and progesterone receptors (ER and PR), gross cystic disease fluid protein-15 (GCDFP-15), and others have traditionally been employed in diagnosing and prognosticating breast cancer [21,22]. This evidence concerns the gene PGR and breast carcinoma.